Edison Investment Research is terminating coverage on Britvic (BVIC). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Consumer |
ADR QuickView
Consumer |
QuickView
Consumer |
ADR QuickView
Consumer |
QuickView
% | 1M | 3M | 12M |
---|---|---|---|
Actual | 9.2 | 13.6 | 9.2 |
Relative | 7.1 | 4.7 | (1.7) |
52 week high/low | 1018.0p/785.5p |
Edison Investment Research is terminating coverage on Oxford Cannabinoid Technologies (OCTP), Britvic (BVIC), Ultimovacs (ULTI), DFR Gold (DFR), The Merchants Trust (MRCH), PB Holding (PBH) and Biodexa Pharmaceuticals (BDRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Previously published reports can still be accessed via our website.